• EPH32 Canadian Pustular Psoriasis Study (CAPPS): Examining Disease Burden, Treatments, and Healthcare Resource Utilization for Generalized Pustular Psoriasis Flares

    Dec 1, 2023, 00:00

  • RWD166 Assessment of Haemophilia Management in Algeria: Challenges and Perspectives

    Dec 1, 2023, 00:00

  • HTA307 Evolving Principles for Defining and Assessing the Economic and Societal Value of Cancer Therapies

    Dec 1, 2023, 00:00

  • HPR94 Treating Early Often Comes Too Late: Ensuring Patient Access to Early Cancer Detection and Treatment in Europe

    Dec 1, 2023, 00:00

  • CO191 Effectiveness of New Generation Heat and Moisture Exchangers and Adhesives for Laryngectomized Patients in Portugal

    Dec 1, 2023, 00:00

  • EE690 Assessing the Relative Budget Impact (BI) of PARP Inhibitor (PARPi) Combination Therapies for Patients with Metastatic Castration Resistant Prostate Cancer (mCRPC) with and Without BRCA1/2 Mutations

    Dec 1, 2023, 00:00

  • MSR133 What Factors Influence the Prescription of Oral Antivirals for COVID-19 in Japan? – a State Transitional Agent-Based Model Analysis

    Dec 1, 2023, 00:00

  • MT66 Characteristics of Patients with Symptomatic Severe Aortic Stenosis Who Underwent Transcatheter Aortic Valve Implantation (TAVI): A Real-World Study in Singapore

    Dec 1, 2023, 00:00

  • EE758 Modelling Visual Acuity Distributions to Inform a Simplified Cost Effectiveness Analysis

    Dec 1, 2023, 00:00

  • SA38 Out-of-Pocket Expenses and Lost Earnings for Breast Cancer Patients Undergoing Treatment: Evidence From the UK Persephone Randomised Controlled Trial Abstract

    Dec 1, 2023, 00:00

  • EPH219 The Effect of Gestational Weight Gain on Pregnancy Outcome

    Dec 1, 2023, 00:00

  • EE409 The Costs of Unaddressed Hearing Loss as a Basis for Cost-Effectiveness Analyses

    Dec 1, 2023, 00:00

  • EE353 Incorporation of Cladribine for Patients With Multiple Sclerosis in a Health Insurance Company in Brazil: Cost-Effectiveness

    Dec 1, 2023, 00:00

  • MSR131 Prospects for Automation of Systemic Literature Reviews (SLRs) With Artificial Intelligence and Natural Language Processing

    Dec 1, 2023, 00:00

  • PCR160 An Integrated Software Platform to Capture Patient Preference Data Throughout the Medical Product Lifecycle

    Dec 1, 2023, 00:00

  • RWD155 Using Real-World-Evidence to Inform Pathway Evaluations at NICE: Benefits and Challenges

    Dec 1, 2023, 00:00

  • CO133 Systematic Literature Review (SLR) of Clinical Data from First-Line Treatment or First-Line Maintenance Therapy for Advanced or Metastatic Ovarian Cancer (2010–2023)

    Dec 1, 2023, 00:00

  • MT29 Understanding How Health Technology Assessment Bodies Select Medical Technology for Review: Results of an Online Survey

    Dec 1, 2023, 00:00

  • HTA173 Time to Access Orphan Medicines in Greece

    Dec 1, 2023, 00:00

  • MT11 Potential Budget Impact of Negative Pressure Wound Therapy with Instillation and Dwell Time Versus Control Therapies for Wound Management in Mexico

    Dec 1, 2023, 00:00

  • EE511 Systematic Review of Cost Effectiveness Assessment Reports of Immune Checkpoint Inhibitors in Early and Advanced/Metastatic Stages of Cancer in France

    Dec 1, 2023, 00:00

  • EPH140 Prevalence Estimation of Thymidine Kinase 2 Deficiency: An Ultra-Rare Autosomal Recessive Mitochondrial Disease

    Dec 1, 2023, 00:00

  • EE425 Estimating HCP Labor Time and Cost Saving with the Use of Rapid Rituximab Infusions Versus Standard Rituximab Infusions for the Treatment of Adults with Follicular Lymphoma and Diffuse Large B-Cell Lymphoma in Induction Phase

    Dec 1, 2023, 00:00

  • EE205 The Impact of the COVID-19 Pandemic on Physician Visits Among Patients Diagnosed with Breast Cancer and Heart Failure in the United States

    Dec 1, 2023, 00:00

  • EE431 Evaluating the Budget Impact of NOVOCART Inject Plus (Ninject) for Symptomatic Knee Cartilage Defects in the NHS

    Dec 1, 2023, 00:00

  • HTA189 A Critical Appraisal of Economic Evaluations in RSV

    Dec 1, 2023, 00:00

  • SA20 The Effectiveness and Safety of Intra-Articular Injection Using Collagen in Knee Osteoarthritis: Systematic Review

    Dec 1, 2023, 00:00

  • EE458 Benefits, Costs and Cost Effectiveness of a Chronic Heart Failure Disease Management Program for Austria – a Decision-Analytic Modeling Study

    Dec 1, 2023, 00:00

  • EPH26 Assessing Cancer Related Premature Mortality and Productivity Loss in Lung, Melanoma, and Breast Cancers in European Regions: Temporal Trends in 2010-2019

    Dec 1, 2023, 00:00

  • OP23 Best Practice for Publication of Health Economics and Outcomes Research/Real-World Evidence (RWE) - a Pilot Study on Guidance Needs and Scope for Development

    Dec 1, 2023, 00:00

  • PCR101 Patient-Centric-Approach and Personalized Clinical Trials to Increase Patients Participation in Drug Development: Insight from a Targeted Literature Review (TLR)

    Dec 1, 2023, 00:00

  • PT29 Predicting PICOs for EU Joint Clinical Assessment: Lessons from PICOs in Relative Effectiveness Assessments (REA) from EUnetHTA Joint Action 3 Project

    Dec 1, 2023, 00:00

  • CO165 Validation of High Risk Criteria in Medication Reconciliation in Major Orthopedic Surgery: A Delphi Study

    Dec 1, 2023, 00:00

  • HTA221 Improving the Reimbursement Application Process: A Predictive Model for Identifying Key Subgroup Specification Parameters for Anti-Obesity Medication

    Dec 1, 2023, 00:00

  • MSR128 Developing a Checklist to Increase Efficiency of VBA Code

    Dec 1, 2023, 00:00

  • MSR12 Analysis of Long-Term Survivorship (LTS) Rates for Stage 2B/2C Melanoma Using Published Real-World Data (RWD) and Data From Randomized Controlled Trials (RCTS)

    Dec 1, 2023, 00:00

  • EE703 Economic Burden and Changing Treatment Landscape in Stargardt Disease: A Literature and Database Review

    Dec 1, 2023, 00:00

  • PCR189 Health-Related Quality of Life and Its Drivers for Patients Living With Glioblastoma in Europe: A Systematic Review

    Dec 1, 2023, 00:00

  • EPH222 Temporal Analysis of Diabetes, Hypertension, and Asthma Prevalen A Comparative Study in European Countries (FRANCE, SPAIN, BELGIUM, ROMANIA, AND ITALY) Using a Real-World Ambulatory Medical Database (2018-2022)

    Dec 1, 2023, 00:00

  • P14 Understanding Patients' Preferences for Remote Monitoring in Parkinson's Disease: Insights from a Mixed-Methods Study

    Dec 1, 2023, 00:00

  • PCR180 The Life with Myasthenia Gravis: Socioeconomic Impact of the Disease on Patients in the Czech Republic

    Dec 1, 2023, 00:00

  • EE200 Cost of Illness of Spinal Muscular Atrophy in Turkey

    Dec 1, 2023, 00:00

  • MT77 Assessing the Environmental Impact Associated With Disruptive Surgical Bleeding

    Dec 1, 2023, 00:00

  • CO36 Comparative Analysis of Coding Schemas for Assessing Major Bleeding Risk Between Non-Vitamin K Antagonist Oral Anticoagulants and Warfarin

    Dec 1, 2023, 00:00

  • EE452 Comparison of Disease Agnostic Healthcare Resource Utilization and Costs Across the US and EU5 Population

    Dec 1, 2023, 00:00

  • HTA270 Integrating Environmental Sustainability into HTA: The State of the Art and Possible Trajectories

    Dec 1, 2023, 00:00

  • MSR17 Can Machine Learning Accurately Predict Payer Behavior?

    Dec 1, 2023, 00:00

  • MSR30 Existing Practices for the Identification, Selection, or Assessment of Registries and Real-Word Data for Regulatory/HTA Purposes: A More-EUROPA Project Systematic Review

    Dec 1, 2023, 00:00

  • HSD115 Genetic Testing in Chinese Breast Cancer Patients: A Survey on Knowledge, Receipt, and Willingness to Pay

    Dec 1, 2023, 00:00

  • EE343 Cost-Utility and Cost-Effectiveness of Rapid Recovery After Joint Replacement: The Payer's Perspective

    Dec 1, 2023, 00:00

  • HTA325 Valuing Life - Decision-Making for Medicines in Australia: A Retrospective Analysis (2020-2022)

    Dec 1, 2023, 00:00

  • MSR142 Multi-State Modelling Incorporating a Combined Additive and Relative Hazards Model

    Dec 1, 2023, 00:00

  • EE326 Cost-Effectiveness of Multiparametric MRI (mpMRI) Compared to No Test for Monitoring of NASH Treatment in the UK

    Dec 1, 2023, 00:00

  • EE378 Real-World Data Establishing HCRU and Costs for the Treatment of Patients With Intermediate- to High-Risk Non-Muscle Invasive Bladder Cancer (NMIBC) Utilizing Medicare Claims Data

    Dec 1, 2023, 00:00

  • EE441 Estimating Changes in Lifetime Tax Revenue and Transfer Payments Associated with the Pediatric Immunization Program in Belgium

    Dec 1, 2023, 00:00

  • MSR77 Can Bayesian Informative Priors Improve Extrapolation of Immature Overall Survival? A Case Study in Advanced Melanoma

    Dec 1, 2023, 00:00

  • CO64 Challenges Associated with Surrogate Endpoints for Healthcare Decision Making in Oncology

    Dec 1, 2023, 00:00

  • RWD136 Use and Potential of Real-World Data (RWD) and Real-World Evidence (RWE) to Inform Pre-Market Regulatory Decisions: A Scoping Review

    Dec 1, 2023, 00:00

  • RWD89 Economic Burden of Advanced Non-Small-Cell Lung Cancer (NSCLC) Patients Harboring KRASG12C Mutation in Spain

    Dec 1, 2023, 00:00

  • EE372 Modeling the Cost-Effectiveness in a Sub-Population: Tepotinib Versus Chemoimmunotherapy (C+IO) in Untreated Patients with Non-Small Cell Lung Cancer (NSCLC) Harboring MET Exon 14 (METEX14) Skipping

    Dec 1, 2023, 00:00

  • HPR23 Preparing Healthcare Systems for Broader Cell Gene Therapy (CGT) Access: What Needs to Change for Pharma, Healthcare Systems, and Patients so All Benefit From CGTs?

    Dec 1, 2023, 00:00

  • HTA239 Network Meta-Analysis on the Efficacy and Safety of Drugs for the Treatment of Acute Myeloid Leukemia in the Elderly

    Dec 1, 2023, 00:00

  • HTA146 Early Access in Fran Reasons for Refusals and Impact on Market Access

    Dec 1, 2023, 00:00

  • HTA191 Discussion of Health Inequalities in the NICE Single Technology Appraisal Process: A Review of Recent Submissions in NHS England Core20PLUS5 Focus Clinical Areas

    Dec 1, 2023, 00:00

  • HPR108 Managed Entry Agreements and Appropriateness Tools Over the Last Three Years in Italy

    Dec 1, 2023, 00:00

  • HSD62 The Emotional and Information Seeking Experience of Locally Advanced Cervical Cancer: Qualitative Research Findings from Brazil

    Dec 1, 2023, 00:00

  • Novel Approaches to Patient Communication, Data Collection, and Involvement in Research

    Dec 1, 2023, 00:00

  • PT10 Opioid Tapering and Its Associations with Risk of Opioid Use Disorder and Mortality Among Older Adults

    Dec 1, 2023, 00:00

  • HTA64 Surrogate Endpoints Used in NICE Technology Appraisals for Oncology and Non-Oncology Indications, 2022–23

    Dec 1, 2023, 00:00

  • PT30 Will Health Technology Assessment (HTA) Bodies in Europe Accept Evidence from an External Control Arm to Supplement Evidence from Clinical Trials for Chronic Diseases?

    Dec 1, 2023, 00:00

  • EE369 Cost-Effectiveness Analysis of Pembrolizumab as a Second-Line Therapy for Advanced Urothelial Carcinoma in the United States

    Dec 1, 2023, 00:00

  • EE570 A Swedish Cost-Utility Analysis of Ferric Derisomaltose Versus Ferric Carboxymaltose in the Treatment of Iron Deficiency Anemia in Patients With Inflammatory Bowel Disease

    Dec 1, 2023, 00:00

  • MSR155 Identifying Relevant Clinical Regulatory and Health Technology Assessment (HTA) Precedents via Artificial Intelligence (AI)

    Dec 1, 2023, 00:00

  • EE403 Economic Analysis of Dupilumab Use in Patients With Chronic Rhinosinusitis With Nasal Polyps in Colombia

    Dec 1, 2023, 00:00

  • HTA165 Unmet Medical Need in Norwegian Clinical Practice and Cost-Effectiveness Analysis of Polatuzumab in Combination With R-CHP Compared to R-CHOP in Patients With Previously Untreated DLBCL With an IPI Score of Three and Above

    Dec 1, 2023, 00:00

  • CO166 Efficacy of Lecanemab in Patients With Early Alzheimer Disease: A Systematic Review and Meta-Analysis

    Dec 1, 2023, 00:00

  • PCR170 The Prevalence and Factors That Affect Perceived Stress, Anxiety, and Depression Among IBD Patients

    Dec 1, 2023, 00:00

  • PCR38 A Systematic Literature Review of the Humanistic Burden Associated with Geographic Atrophy

    Dec 1, 2023, 00:00

  • HSD6 The CONNACT Program for Knee Osteoarthritis Can Potentially Lower 2-Year Costs of Outpatient Treatment

    Dec 1, 2023, 00:00

  • CO141 Assessing the Impact of Additional Follow-up Data on Disease-Free Survival (DFS) Projections of Nivolumab and Surveillance in High-Risk, Muscle-Invasive Urothelial Carcinoma (MIUC) Patients Within the CheckMate-274 Trial

    Dec 1, 2023, 00:00

  • EPH142 Fibrodysplasia Ossificans Progressiva (FOP): Prevalence Estimate By Hospitalization Data

    Dec 1, 2023, 00:00

  • EE266 A Cost-Utility Analysis of Ferric Derisomaltose Versus Ferric Carboxymaltose in Patients With Iron Deficiency Anemia in China

    Dec 1, 2023, 00:00

  • EE727 The Budgetary Impact of Introducing Expanded Haemodialysis, Enabled by Theranova (HDX), Compared to High-Flux Haemodialysis (HF-HD) in Private Sector in the Kingdom of Saudi Arabia

    Dec 1, 2023, 00:00

  • HTA44 Broadening the HTA of Medical AI: A Review of Policy Reports to Inform Decision Makers

    Dec 1, 2023, 00:00

  • CO174 Real World Data of Daratumumab Treatment in Patient with Multiple Myeloma: A Portuguese Study

    Dec 1, 2023, 00:00

  • HTA27 Use of Clinical Outcome Assessments in Health Technology Appraisals for Rare Disease Indications: A Review of UK, US, and Canadian Submissions

    Dec 1, 2023, 00:00

  • PCR152 Exploring Which Proxy Conditions Are Conceptually Similar to Alopecia Areata, in Terms of Patients Lived Experience and Health-Related Quality of Life: A Scoping Review to Inform HTA Submission

    Dec 1, 2023, 00:00

  • MSR119 Statistical Methods to Examine Racial and Ethnic Disparities in the Surgical Literature: A Review and Recommendations for Improvement

    Dec 1, 2023, 00:00

  • PCR203 A Qualitative Study of the Health-Related Quality of Life Impact of Geographic Atrophy on Patients

    Dec 1, 2023, 00:00

  • CO143 Identifying Evidence Gaps for Hemophilia B by Developing a Factsheet Using Targeted Review of Literature: Shaping the Future Real-World Evidence Studies

    Dec 1, 2023, 00:00

  • HTA90 Quality of Clinical Evidence Submitted to a National HTA Agency in Ireland: 10 Years of Drugs for Oncology

    Dec 1, 2023, 00:00

  • MT41 Single-Use Vs Reusable Endoscope Reprocessing: A Staff Survey on Safety and Effectiveness

    Dec 1, 2023, 00:00

  • EPH72 Polysubstance Use of Psychoactive Stimulants, Suicidal Behavior, and Mental Health Disability Among Women of Reproductive Age

    Dec 1, 2023, 00:00

  • CO76 Does Next Generation Sequencing (NGS) Improve Outcome in Non-Small Cell Lung Cancer (NSCLC)? A Real-World Data (RWD) Example

    Dec 1, 2023, 00:00

  • EE579 Cost Consequences of Using Clevidipine in Neurological Emergencies from the Perspective of a US Hospital

    Dec 1, 2023, 00:00

  • EE700 Are Acute Therapies and Curative Drugs More Affordable Than Chronic Treatments in Rare Diseases? An Analysis of the Top 10 Most Expensive Drugs in the US Compared with Germany

    Dec 1, 2023, 00:00

  • HSD88 The Propensity to Receive Haematopoietic Stem Cell Transplantation in Diffuse Large B-Cell Lymphoma Patients Based on Sex, Ethnicity, and Deprivation: Results From National Cancer Registry Linked Real-World Datasets in England

    Dec 1, 2023, 00:00

  • EPH150 Impact CKD: The Growing Burden of CKD in Spain

    Dec 1, 2023, 00:00

  • EPH70 Claims Data Analysis of Health Care Resource Use and Costs of Respiratory Syncytial Virus Prevention in Infants in Germany

    Dec 1, 2023, 00:00

  • PT38 Budget Impact Analysis of rFVIII Glycopegylated-Exei for the Treatment of Haemophilia A in Colombia

    Dec 1, 2023, 00:00

  • HSD69 Maternal and Foeto-Neonatal Characteristics of Childbirths in Ethiopia: A Multilevel Mixed-Effect Analysis

    Dec 1, 2023, 00:00

  • HTA58 Scoping Mock-Up: What Can We Learn From an EU-4 Experiment for EU HTA?

    Dec 1, 2023, 00:00

  • EE8 Еconomic Evaluation of Intravascular Ultrasound (IVUS) for Imaging in Patients with Coronary Artery Disease in Bulgaria

    Dec 1, 2023, 00:00

  • HTA222 Antimicrobial Resistan Evolving Changes in Health Technology Assessment and Reimbursement of New Treatment Options

    Dec 1, 2023, 00:00

  • P2 NICE's Pathways Pilot: Incorporating Disease-Specific Reference Models Into Health Technology Assessment in England

    Dec 1, 2023, 00:00

  • RWD49 Real-World Evidence From a Federated Data Network to Reduce Uncertainty in the Long-Term Extrapolations of Oncology Treatments

    Dec 1, 2023, 00:00

  • RWD129 Cost Effectiveness of Onasemnogene Abeparvovec in Infants with Presymptomatic Spinal Muscular Atrophy in Italy

    Dec 1, 2023, 00:00

  • EE324 Clinical and Economic Evaluation of the Potential Implementation of P4P for Type 2 Diabetes in Bulgaria

    Dec 1, 2023, 00:00

  • MT40 Trends of Use of Knotless Tissue Control Devices and Smooth Sutures in Robotic Ventral Hernia Repair: A Retrospective Database Analysis

    Dec 1, 2023, 00:00

  • MSR122 Relationship Between 3-Meter Backward Walk Test and Grip Strength Test in Community-Dwelling Young-Older Adults

    Dec 1, 2023, 00:00

  • PCR64 EQ-5D Utility Scores in Patients With Clinically Suspect Arthralgia (CSA): Differences Between Progressors and Non-Progressors

    Dec 1, 2023, 00:00

  • PT37 A Systematic Review of Modelling Approaches in Economic Evaluations of Treatments for Inherited Bleeding Disorders

    Dec 1, 2023, 00:00

  • HSD91 High Costs, Low Quality of Life, Reduced Survival, and Room for Improving Treatment: An Analysis of Burden and Unmet Needs in Glioma

    Dec 1, 2023, 00:00

  • HSD85 Patterns and Correlates of Physical Activity Among Nigerian Community-Dwelling Older Adults

    Dec 1, 2023, 00:00

  • MSR72 The Impact of Life Expectancy Exclusion Criteria on Survival Curve Extrapolation

    Dec 1, 2023, 00:00

  • PCR111 Which Body Functions and Activities Matter for Stroke Patients? Study Protocol for Best–Worst Scalings to Value Core Elements of the ICF

    Dec 1, 2023, 00:00

  • EPH144 Annual Health Insurance Treatment Cost of Female Infertility, Unspecified Based on Routinely Collected Financing Data Between 2010-2019

    Dec 1, 2023, 00:00

  • EPH121 Contraindicated Remdesivir Use Among Individuals Hospitalized Due to COVID-19: According to the Danish Treatment Guidelines

    Dec 1, 2023, 00:00

  • PCR73 Sensitivity of EQ-5D to Assess Health-Related Quality of Life (HRQoL) for Triple-Class Exposed (TCE) Relapsed/Refractory Multiple Myeloma (RRMM): KarMMa-3 Case Study Exploring EQ-5D Mapped from Disease-Specific Instruments

    Dec 1, 2023, 00:00

  • CO56 Radiographic Progression Free Survival as a Surrogate Endpoint for Overall Survival Among Men With Metastatic Castration-Resistant Prostate Cancer

    Dec 1, 2023, 00:00

  • HPR143 Standardizing Cross-Border Access to Advanced Therapies

    Dec 1, 2023, 00:00

  • EE287 Epidemiologic and Economic Impact of COVID-19 Vaccination Among at-Risk Individuals and Individuals Aged ≥60 Years in Germany

    Dec 1, 2023, 00:00

  • MSR6 Application of the Atlas Algorithm to Identify the Carboplatin+Gemcitabine Regimen in Patients with Metastatic Triple-Negative Breast Cancer (MTNBC) through the French Nationwide Hospital Discharge Database (PMSI)

    Dec 1, 2023, 00:00

  • PCR48 Health-Related Quality of Life in Children with Pneumococcal Disease: What Can We Learn from Cost-Effectiveness Analyses of Pneumococcal Vaccines?

    Dec 1, 2023, 00:00

  • SA15 A Systematic Review to Assess How Cure Is Modelled and Subsequently Evaluated in Health Technology Submissions to the National Institute for Health and Care Excellence (NICE)

    Dec 1, 2023, 00:00

  • PCR49 A Preliminary Comparison between Analytical Hierarchy Process and Discrete Choice Experiment in Health State Preferences in Hong Kong SAR, China

    Dec 1, 2023, 00:00

  • EE654 Occupational Impact of Tardive Dyskinesia: A Cross-Sectional, International Survey Assessing the Perceptions and Experiences of Patients With TD and Physicians Who Treat TD

    Dec 1, 2023, 00:00

  • EE443 Burden of Hospitalization Related to Adult Herpes Zoster Infection in Portugal

    Dec 1, 2023, 00:00

  • HPR96 Pieces: Productivity Losses Due to Premature Mortality From Cancer in Greece

    Dec 1, 2023, 00:00

  • PCR87 Collecting Exploratory Patient Preference Data Using an Efficient Approach: An Example in Rare Diseases

    Dec 1, 2023, 00:00

  • RWD12 Wayfind-R: A Global, Real-World Precision Oncology Registry – Socioeconomic Features

    Dec 1, 2023, 00:00

  • HTA205 EU Joint Clinical Assessments on Health Technologies Is Approaching—Are We Prepared?

    Dec 1, 2023, 00:00

  • HTA263 NICE Listens: Engaging the Public on How Environmental Sustainability Should Be Considered in Health Technology Assessment and Guideline Development

    Dec 1, 2023, 00:00

  • PCR45 Vascular Access Devices: A Comparative Analysis of Complications and Their Cost Implications

    Dec 1, 2023, 00:00

  • PT47 High-Volume Hospitals Experience Fewer Postoperative Complications After Neonatal Surgery: Analyses of the National Clinical Database Pediatric Surgical Registry in Japan

    Dec 1, 2023, 00:00

  • PCR15 Impact of Amyotrophic Lateral Sclerosis on Work and Daily Living: Results from a Real-World Survey

    Dec 1, 2023, 00:00

  • EE26 Deprescribing of Proton Pump Inhibitors in Elderly Patients: A Cost-Effectiveness Analysis

    Dec 1, 2023, 00:00

  • MT36 Roadmap for Evidence Generation on Remote Monitoring Devices for Parkinson’s Disease

    Dec 1, 2023, 00:00

  • CO115 The Interpretation and Grading of Evidence Derived From Interim Analyses for the Assessment of the Pharmacotherapeutic Efficacy of Medicines

    Dec 1, 2023, 00:00

  • MT32 Predictive Factors of Communicating Health-Related Information through the Internet Among Adults in South Korea: A Cross-Sectional Study

    Dec 1, 2023, 00:00

  • EPH8 Insulin Analogs in Type 1 Diabetes Treatment: An Incorporation Process Study in Brazilian Unified Health System (SUS)

    Dec 1, 2023, 00:00

  • EE714 A De Novo Cost-Effectiveness Model to Evaluate the Real-World Value of Pegcetacoplan in the Treatment of Geographic Atrophy Secondary to Age-Related Macular Degeneration in the United States

    Dec 1, 2023, 00:00

  • HPR68 Comprehensive Genomic Profiling Approaches in Europe and the US: A Review of Guidelines and Recommendations for Solid Tumors

    Dec 1, 2023, 00:00

  • HPR67 Utilisation of Intermittent and Real-Time Continuous Blood Glucose Monitoring in the Irish Healthcare System

    Dec 1, 2023, 00:00

  • EPH151 Prevalence of Risk Factors for Serious Adverse Events Among Rheumatoid Arthritis Patients Prescribed Janus Kinase Inhibitors and Tumor Necrosis Factor Inhibitors: A Merative Marketscan Cross-Sectional Study

    Dec 1, 2023, 00:00

  • EE172 An Early Economic Analysis of the Costs and Benefits of Medical Alert Assistance Dogs (MAADS) in the Management of Emergency Episodes for People with Postural Tachycardia Syndrome (POTS) Using Real-World Evidence (RWE)

    Dec 1, 2023, 00:00

  • RWD45 Describing Medication Switching Patterns Among Adults With Rheumatoid Arthritis From 2016-2022 Using Real-World Data

    Dec 1, 2023, 00:00

  • EPH84 Burden of Respiratory Syncytial Virus in Children ≤ 2 Years of Age in Germany: Retrospective Analysis of Health Claims Data from 2014-2019

    Dec 1, 2023, 00:00

  • EPH68 What Are the Main Symptoms of Long COVID? Real World Medical Data Cross-Referenced with Social Network Content

    Dec 1, 2023, 00:00

  • Using Discrete Choice Experiments to Elicit Carers' and Patients' Preferences

    Dec 1, 2023, 00:00

  • EE633 Analysis of Cost-Effectiveness in Switzerland for a New Implantable Device to Treat Chronic Gastroesophageal Reflux Disease

    Dec 1, 2023, 00:00

  • HPR40 DiGA in Germany: Achievable Prices After Price Negotiation or a Decision of the Arbitration Board

    Dec 1, 2023, 00:00

  • RWD24 Decision Making and the Questions Raised When Real World Evidence From a Federated Data Network Conflicts With RCT Data: A Use Case on COVID-19 Treatments

    Dec 1, 2023, 00:00

  • P47 How Do HTA Agencies Manage Uncertainties in the Long-Term Clinical Benefit of Gene Therapies? An Analysis of Recent Gene Therapy HTAs in England, Germany, France, Italy, Canada, and the United States

    Dec 1, 2023, 00:00

  • RWD152 Describing the Management of Spondyloarthropathies in French Primary Care: An EHR Study Exploring Regional Differences

    Dec 1, 2023, 00:00

  • P30 Do Novel Oncology Combination Therapies Have a Place Within the EU Legislative Framework? The Impact of Challenges for Novel Combination Therapies on Equality of Access Between European Patients

    Dec 1, 2023, 00:00

  • EE434 Analysis of the Clinical and Economic Impact of High Protein Concentration Ons in a Spanish Hospital Setting

    Dec 1, 2023, 00:00

  • SA16 Assessing the Validity of Observational Filters for Systematic and Rapid Literature Reviews

    Dec 1, 2023, 00:00

  • HTA6 The Value of Looking Beyond Overall Survival: The Role of Oncology-Relevant Endpoints in HTA / Payer Decision-Making

    Dec 1, 2023, 00:00

  • EPH247 Survival and Risk of Death Analysis of Patients with Myelofibrosis Treated with Ruxolitinib

    Dec 1, 2023, 00:00

  • RWD95 Eosinophilic Granulomatosis with Polyangiitis: Estimation of the Clinical and Economic Burden in Fran A Real-World Retrospective Study Based on the National Health Data System (SNDS)

    Dec 1, 2023, 00:00

  • SA4 Characterization of Demography and Comorbidity in Newly Diagnosed Multiple Myeloma Patients in the UK

    Dec 1, 2023, 00:00

  • EPH138 Descriptive Analysis of Communication About Cancer Prevention and Screening on the Social Network Twitter

    Dec 1, 2023, 00:00

  • HSD103 Lifestyle Modifications and Medicines as the Foundation of Clinical Practice Guidelines

    Dec 1, 2023, 00:00

  • EE623 Open Data Available in Fran A Great Asset to Study Real-Life Trends for Disease Burden - An Example With Bariatric Surgery Procedures

    Dec 1, 2023, 00:00

  • EE406 Budget Impact Analysis of Dupilumab 200 Mg for Treatment of Adolescent and Adult With Severe Asthma in Algerian Setting

    Dec 1, 2023, 00:00

  • HSD100 Opportunities and Barriers to Hub-and-Spoke Delivery Models for Advanced Therapy Medicinal Products in Europe: A Scoping Review

    Dec 1, 2023, 00:00

  • RWD121 Moment Registry (MET NON SMALL CELL CANCER REGISTRY) for Advanced Non-Small Cell Lung Cancer (ANSCLC) Harboring MET Exon 14 (METEX14) Skipping

    Dec 1, 2023, 00:00

  • HSD32 Long COVID: Clinical Characteristics and Management in the Real-World Setting

    Dec 1, 2023, 00:00

  • HTA102 Exploring Potential Inequity in Access to Medicines for Ultra-Rare Disease in England and Scotland: SMC Ultra-Orphan Pathway Versus NICE HST

    Dec 1, 2023, 00:00

  • EE183 Cost-Effectiveness of Raltegravir Oral Granules Prophylaxis in Neonates to Prevent HIV Mother-to-Child Transmission in Brazil

    Dec 1, 2023, 00:00

  • EE140 Comparison of the Clinical and Economic Impact of Two MRNA COVID-19 Vaccines in High Risk Individuals in Japan

    Dec 1, 2023, 00:00

  • SA50 Economic Evaluation of Robotic-Assisted Surgery: Methods, Challenges, and Opportunities

    Dec 1, 2023, 00:00

  • HTA330 EU HTA: How Will Joint Clinical Assessment (JCA) Address the Specifics of Gene Therapies?

    Dec 1, 2023, 00:00

  • HTA63 Qualitative Analysis of Value-Based Contract Experience, Perception, and Future Adoption across Geographies

    Dec 1, 2023, 00:00

  • EE741 Costs of Breast Surgery Reconstruction and Mastectomy in France between 2019 and 2021

    Dec 1, 2023, 00:00

  • MSR99 Application of Artificial Intelligence in Literature Reviews

    Dec 1, 2023, 00:00

  • SA7 Emerging Biomarkers in Metastatic Castration Resistant Prostate Cancer As Evaluated in Early Phase Clinical Trials: A Targeted Literature Review

    Dec 1, 2023, 00:00

  • HPR89 Payer Rejections and Prescription Abandonment Among Patients Newly Prescribed Oral Anticoagulants for Venous Thromboembolism

    Dec 1, 2023, 00:00

  • EE467 Cost-Effectiveness and Budget Impact Analyses Using Real World Data from Brazilian Health Care Insurance Companies in the Treatment of Iron Deficiency in Patients with Heart Failure

    Dec 1, 2023, 00:00

  • Estimated Savings From Using Added Therapeutic Benefit and Therapeutic Reference Pricing in United States Medicare Drug Price Negotiations [Editor's Choice]

    Nov 1, 2023, 00:00

  • Table of Contents

    Nov 1, 2023, 00:00

  • On the (Near) Equivalence of Welfarist and Extra-Welfarist Methods to Value Healthcare With Implications for Assessing Equity [Editor's Choice]

    Nov 1, 2023, 00:00

  • Cancer Drug Prices in the United States: Efficacy, Innovation, Clinical Trial Evidence, and Epidemiology [Editor's Choice]

    Nov 1, 2023, 00:00

  • Influence of Self-Reported Health Impairments on German EQ-5D-5L Values

    Nov 1, 2023, 00:00

  • A Comparison of Relative-Efficacy Estimate(S) Derived From Both Matching-Adjusted Indirect Comparisons and Standard Anchored Indirect Treatment Comparisons: A Review of Matching-Adjusted Indirect Comparisons

    Nov 1, 2023, 00:00

  • Copyright/Subscription

    Nov 1, 2023, 00:00

  • The Feasibility and Validity of Preference-Based Quality of Life Measures With Informal Carers: A Think-Aloud Study

    Nov 1, 2023, 00:00

  • Evolving Use of Health Technology Assessment in Medical Device Procurement—Global Systematic Review: An ISPOR Special Interest Group Report

    Nov 1, 2023, 00:00

  • Toward Best Practices for Economic Evaluations of Tumor-Agnostic Therapies: A Review of Current Barriers and Solutions [Editor's Choice]

    Nov 1, 2023, 00:00

  • Can Independently Elicited Adult- and Child-Perspective Health-State Utilities Explain Priority Setting?

    Nov 1, 2023, 00:00

  • UK Valuation of EQ-5D-5L, a Generic Measure of Health-Related Quality of Life: A Study Protocol

    Nov 1, 2023, 00:00

  • Editorial Board

    Oct 30, 2023, 08:36

  • The Evolving Nature of Health Technology Assessment: A Critical Appraisal of NICE’s New Methods Manual [Editor's Choice]

    Oct 1, 2023, 00:00

  • Assessment of Patient-Reported Outcomes in Industry-Sponsored Phase I Oncology Studies: Considerations for Translating Theory Into Practice

    Oct 1, 2023, 00:00

  • Copyright/Subscription

    Oct 1, 2023, 00:00

  • A Qualitative Investigation to Develop an Adapted Version of the EQ-5D-Y-3L for Use in Children Aged 2-4 Years

    Oct 1, 2023, 00:00

  • A Decade of Health Innovation: The Impact of New Medicines on Patient Health and the Implications for NICE’s Size of Benefit Multiplier

    Oct 1, 2023, 00:00

  • Recognizing the Broader Value of Meningococcal Vaccination: A Matter of Evidence, Ability, or Willingness?

    Oct 1, 2023, 00:00

  • Estimating the US Baseline Distribution of Health Inequalities Across Race, Ethnicity, and Geography for Equity-Informative Cost-Effectiveness Analysis [Editor's Choice]

    Oct 1, 2023, 00:00

  • Table of Contents

    Oct 1, 2023, 00:00

  • A Value Framework to Assess Patient-Facing Digital Health Technologies That Aim to Improve Chronic Disease Management: A Delphi Approach [Editor's Choice]

    Oct 1, 2023, 00:00

  • Adaptive Health Technology Assessment: A Scoping Review of Methods [Editor's Choice]

    Oct 1, 2023, 00:00

  • Consolidated Health Economic Evaluation Reporting Standards - Value of Information (CHEERS-VOI): Explanation and Elaboration [Editor's Choice]

    Oct 1, 2023, 00:00

  • Perspectives on Patient-Reported Outcome Data After Treatment Discontinuation in Cancer Clinical Trials

    Oct 1, 2023, 00:00

  • Does Scoring Method Impact Estimation of Significant Individual Changes Assessed by Patient-Reported Outcome Measures? Comparing Classical Test Theory Versus Item Response Theory

    Oct 1, 2023, 00:00

  • Author Reply

    Oct 1, 2023, 00:00

  • Extending Beyond Bagust and Beale: Fully Parametric Piecewise Exponential Models for Extrapolation of Survival Outcomes in Health Technology Assessment

    Oct 1, 2023, 00:00

  • Comparisons of Medical Cost Trajectories Between Non-Hispanic Black and Non-Hispanic White Patients With Newly Diagnosed Localized Prostate Cancer

    Oct 1, 2023, 00:00

  • Postacute Expenditures Among Patients Discharged Home After Stroke or Transient Ischemic Attack: The COMprehensive Post-Acute Stroke Services (COMPASS) Trial

    Oct 1, 2023, 00:00

  • Economic Evaluations of Guideline-Directed Medical Therapies for Heart Failure With Reduced Ejection Fraction: A Systematic Review

    Oct 1, 2023, 00:00

  • The Integration of Value Assessment and Social Network Methods for Breast Health Navigation Among African Americans

    Oct 1, 2023, 00:00

  • Reporting Answer Categorization and Scoring Methods in the Criteria for Health Economic Quality Evaluation (CHEQUE) Tool

    Oct 1, 2023, 00:00

  • Editorial Board

    Sep 22, 2023, 12:54

  • Whose Time Trade-Off Should Be Used? Anchoring Discrete Choice Experiment Latent Utilities in Health State Valuation

    Sep 1, 2023, 00:00

  • A New Type 2 Diabetes Microsimulation Model to Estimate Long-Term Health Outcomes, Costs, and Cost-Effectiveness [Editor's Choice]

    Sep 1, 2023, 00:00

  • Streamlining Global and Local Data on HIV: Underscoring Role of Institutions and Ethics in Improving Quality of HIV Research

    Sep 1, 2023, 00:00

  • Incorporating Prior Beliefs Into Meta-Analyses of Health-State Utility Values Using the Bayesian Power Prior

    Sep 1, 2023, 00:00

  • Reimagining Patient Data Access for Researchers

    Sep 1, 2023, 00:00

  • A Rapid Review on the Value of Biobanks Containing Genetic Information

    Sep 1, 2023, 00:00

  • Impacts of Chronic Obstructive Pulmonary Disease Care Pathway on Healthcare Utilization and Costs: A Matched Multiple Control Cohort Study in Saskatchewan, Canada

    Sep 1, 2023, 00:00

  • “What’s Sex and Gender Got to Do With It?” A Scoping Review of Sex- and Gender-Based Analysis in Pharmacoepidemiologic Studies of Medication Adherence

    Sep 1, 2023, 00:00

  • A Model for Evaluating Total Costs of Care and Cost Savings of Specialty Condition-Based Care for Hip and Knee Osteoarthritis in an Integrated Practice Unit

    Sep 1, 2023, 00:00

  • Incorporating Added Therapeutic Benefit and Domestic Reference Pricing Into Medicare Payment for Expensive Part B Drugs [Editor's Choice]

    Sep 1, 2023, 00:00

  • The Societal Impact of Inclisiran in England: Evidence From a Population Health Approach

    Sep 1, 2023, 00:00

  • Evaluation of Diversity of Clinical Trials Informing Health Technology Assessments in the United States: A 5-Year Analysis of Institute for Clinical and Economic Review Assessments

    Sep 1, 2023, 00:00

  • Does EQ-5D Tell the Whole Story? Statistical Methods for Comparing the Thematic Coverage of Clinical and Generic Outcome Measures, With Application to Breast Cancer [Editor's Choice]

    Sep 1, 2023, 00:00

  • Table of Contents

    Sep 1, 2023, 00:00

  • US Residents’ Preferences for Sharing of Electronic Health Record and Genetic Information: A Discrete Choice Experiment

    Sep 1, 2023, 00:00

  • Data Privacy and Health: How Do We Achieve the Right Balance? [Editor's Choice]

    Sep 1, 2023, 00:00

  • Use of Big Data and Ethical Issues for Populations With Substance Use Disorder

    Sep 1, 2023, 00:00

  • Editorial Board

    Sep 1, 2023, 00:00

  • Personal Location as Health-Related Data: Public Knowledge, Public Concern, and Personal Action

    Sep 1, 2023, 00:00

  • Mothers’ Views on the Storage and Usage of Their Children’s Biological Material Under the Danish Biobanking Model: A Narrative Approach Using Epistemic Injustice

    Sep 1, 2023, 00:00

  • Evaluating the Value for Money of Precision Medicine from Early Cycle to Market Access: A Comprehensive Review of Approaches and Challenges [Editor's Choice]

    Sep 1, 2023, 00:00

  • Balancing Data Privacy With Access to Health Services and Research: Facilitating Confidential Information Sharing in US Multisystem Collaborations

    Sep 1, 2023, 00:00

  • Copyright/Subscription

    Sep 1, 2023, 00:00

  • Frameworks for Health Technology Assessment at an Early Stage of Product Development: A Review and Roadmap to Guide Applications

    Aug 1, 2023, 00:00

  • Patients’ and Healthcare Professionals’ Perspectives on Better Use of Patient-Reported Outcome Measures in Head and Neck Cancer

    Aug 1, 2023, 00:00

  • Dynamic Mortality Modeling: Incorporating Predictions of Future General Population Mortality Into Cost-Effectiveness Analysis

    Aug 1, 2023, 00:00

  • A Systematic Literature Review of Gaps and Challenges in Value Assessment of Biosimilars: An ISPOR Special Interest Group Report [Editor's Choice]

    Aug 1, 2023, 00:00

  • The Economic Cost of Thyroid Cancer in France and the Corresponding Share Associated With Treatment of Overdiagnosed Cases [Editor's Choice]

    Aug 1, 2023, 00:00

  • Inclusion of Environmental Spillovers in Applied Economic Evaluations of Healthcare Products

    Aug 1, 2023, 00:00

  • Copyright/Subscription

    Aug 1, 2023, 00:00

  • Health Utility Analysis of Tepotinib in Patients With Non-Small Cell Lung Cancer Harboring ME T Exon 14 Skipping

    Aug 1, 2023, 00:00

  • Emulating Target Trials With Real-World Data to Inform Health Technology Assessment: Findings and Lessons From an Application to Emergency Surgery

    Aug 1, 2023, 00:00

  • Resurrecting Multiattribute Utility Function: Developing a Value Set for Health Utility for Glaucoma

    Aug 1, 2023, 00:00

  • Comparing Patient-Reported Outcomes Measurement Information System Computer Adaptive Testing With Existing Measures After Operative Interventions for Extremity Fractures

    Aug 1, 2023, 00:00

  • Developing Criteria for Health Economic Quality Evaluation Tool [Editor's Choice]

    Aug 1, 2023, 00:00

  • Designing Guidelines for Those Who Do Not Follow Them: The Impact of Adherence Assumptions on Optimal Screening Guidelines

    Aug 1, 2023, 00:00

  • Table of Contents

    Aug 1, 2023, 00:00

  • Cost-Effectiveness and Long-Term Savings of the Bright Bodies Intervention for Childhood Obesity

    Aug 1, 2023, 00:00

  • How Uncertainty Matters Under Risk Neutrality

    Aug 1, 2023, 00:00

  • Best Practice Recommendations for Electronic Patient-Reported Outcome Dataset Structure and Standardization to Support Drug Development [Editor's Choice]

    Aug 1, 2023, 00:00

  • The Economic Potential of Smoking Cessation Interventions at the Point of Diagnosis of Non–Small Cell Lung Cancer

    Aug 1, 2023, 00:00

  • The Healthcare Cost Burden of Asthma in Children: A Longitudinal Population-Based Study

    Aug 1, 2023, 00:00

  • Instructions for Authors

    Aug 1, 2023, 00:00

  • Editorial Board

    Jul 28, 2023, 10:22

  • Opportunities and Barriers to the Development and Use of Open Source Health Economic Models: A Survey

    Jul 1, 2023, 00:00

  • The Associations of Prescription Drug Insurance and Cost-Sharing With Drug Use, Health Services Use, and Health: A Systematic Review of Canadian Studies

    Jul 1, 2023, 00:00

  • Deriving Meaningful Aspects of Health Related to Physical Activity in Chronic Disease: Concept Elicitation Using Machine Learning–Assisted Coding of Online Patient Conversations

    Jul 1, 2023, 00:00

  • Recommendations on the Selection, Development, and Modification of Performance Outcome Assessments: A Good Practices Report of an ISPOR Task Force

    Jul 1, 2023, 00:00

  • Developing, Selecting, and Modifying Performance Outcome Assessments

    Jul 1, 2023, 00:00

  • Public Preferences for Policies to Promote COVID-19 Vaccination Uptake

    Jul 1, 2023, 00:00

  • Using Time Trade-Off Values to Estimate EQ-5D-Y Value Sets: An Exploratory Study

    Jul 1, 2023, 00:00

  • Valuing the EQ Health and Wellbeing Short Using Time Trade-Off and a Discrete Choice Experiment: A Feasibility Study

    Jul 1, 2023, 00:00

  • Methods to Adjust Willingness-to-Pay Measures for Severity of Illness [Editor's Choice]

    Jul 1, 2023, 00:00

  • Do Reimbursement Recommendations by the Canadian Agency for Drugs and Technology in Health Translate Into Coverage Decisions for Orphan Drugs in the Canadian Province of Ontario? [Editor's Choice]

    Jul 1, 2023, 00:00

  • A Direct Comparison of the Measurement Properties of EQ-5D-5L, PROMIS-29+2 PROMIS Global Health Instruments and EQ-5D-5L and PROPr Utilities in a General Population Sample [Editor's Choice]

    Jul 1, 2023, 00:00

  • Cost-Effectiveness of Extracorporeal Photopheresis for the Treatment of Patients With Erythrodermic Stage T4, M0) Cutaneous T-Cell Lymphoma in the Australian Setting

    Jul 1, 2023, 00:00

  • Quality-Adjusted Life Expectancy Norms for Italy

    Jul 1, 2023, 00:00

  • The Value of Vaccines in Maintaining Health System Capacity in England

    Jul 1, 2023, 00:00

  • Value of an Integrated Home Dialysis Model in the United Kingdom: A Cost-Effectiveness Analysis

    Jul 1, 2023, 00:00

  • Table of Contents

    Jul 1, 2023, 00:00

  • Revising the Suspected-Cancer Guidelines: Impacts on Patients’ Primary Care Contacts and Costs

    Jul 1, 2023, 00:00

  • Targeting Diabetes Prevention to More Disadvantaged Groups Improves Cost-Effectiveness: Implications of Inequality in Type 2 Diabetes From Theoretical Interventions

    Jul 1, 2023, 00:00

  • Health Technology Assessment–Informed Decision Making by the Federal Joint Committee/Institute for Quality and Efficiency in Health Care in Germany and the National Institute for Health and Care Excellence in England [Editor's Choice]

    Jul 1, 2023, 00:00

  • Designing a Value-Based Formulary for a Commercial Health Plan: A Simulated Case Study of Diabetes Medications [Editor's Choice]

    Jul 1, 2023, 00:00

  • Intention to Treat or per Protocol? Overly Optimistic Findings Regarding the Cost-Effectiveness of 99DOTS, a Tuberculosis Digital Adherence Technology

    Jul 1, 2023, 00:00

  • Copyright/Subscription

    Jul 1, 2023, 00:00

  • The Impact of Subclinical Hypothyroidism on the Quality of Life During Pregnancy: Mapping 5-Level Version of EQ-5D and ThyPRO-39

    Jul 1, 2023, 00:00

  • Use of Utility and Disability Weights in Economic Evaluation of Pediatric Vaccines

    Jul 1, 2023, 00:00

  • Editorial Board

    Jun 28, 2023, 09:01

  • Editorial Board

    Jun 1, 2023, 08:52

  • CO124 Real-World Reduction of Oral Corticosteroid Use in Patients Treated with Dupilumab and with Moderate-to-Severe Asthma

    Jun 1, 2023, 00:00

  • MT38 Novel Data Capture Method for the Identification of Potential Flare Events in Chronic Diseases Via Patient Self-Tracking: Insights from Use Case in Sickle Cell Disease (SCD)

    Jun 1, 2023, 00:00

  • EE45 Cost-Effectiveness of Venetoclax in Combination with Rituximab in Relapsed/Refractory Chroniclymphocytic Leukemia in Four Gulf Countries

    Jun 1, 2023, 00:00

  • RWD50 Characteristics of Health Insurance Coverage in Patients with Active and Nonactive Progressive Multiple Sclerosis in the United States

    Jun 1, 2023, 00:00

  • Medical Technologies

    Jun 1, 2023, 00:00

  • PCR70 Patient and Physician Concordance in Treatment Satisfaction and Symptom Severity Among Male and Female Myasthenia Gravis Patients in the United States and Five European Countries

    Jun 1, 2023, 00:00

  • CO174 Prescription Patterns of Antidiabetic Agent and Renal Effectiveness Among Patients with Diabetic Kidney Disease

    Jun 1, 2023, 00:00

  • Current Health State Affected Patient Preferences More Than Disease Status: A Discrete Choice Experiment in Multiple Myeloma

    Jun 1, 2023, 00:00

  • EE562 Cost-Effectiveness of the Dengue Vaccine TAK-003 in Thailand

    Jun 1, 2023, 00:00

  • SA33 Healthcare Utilization Among Veterans with Alzheimer's Disease Identified from Clinical Notes

    Jun 1, 2023, 00:00

  • EE248 Patient-Informed Value Elements for Economic Evaluation of Treatment for Major Depressive Disorder: A Systematic Review and Synthesis

    Jun 1, 2023, 00:00

  • CO163 Associations between Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors (EGFR-TKIS) and Venous Thromboembolism Among Older Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)

    Jun 1, 2023, 00:00

  • RWD68 Early Optimal Recovery As a Composite Outcome to Measure Value of Care in Patients Undergoing Primary Total Knee Arthroplasty with a New Implant Design

    Jun 1, 2023, 00:00

  • HPR146 Specialty Pharmacy Use and Adherence to Oral Anticancer Medications for Breast Cancer and Prostate Cancer: Implications for Medicare Part D Policy

    Jun 1, 2023, 00:00

  • EPH86 Associations between Depression and HIV Testing / Risk Behaviors in the United States

    Jun 1, 2023, 00:00

  • CO43 Burden of Surgery in Desmoid Tumors

    Jun 1, 2023, 00:00

  • RWD71 Managing Uncertainty in US and Spain: How Can Outcomes-Based Agreements Provide Solutions to This?

    Jun 1, 2023, 00:00

  • EPH26 Barriers to in-Person Focus Group Participation during the Third-Year of COVID-19 Pandemic: A Case Study of Colorectal Cancer (CRC) Screening in Underrepresented Groups

    Jun 1, 2023, 00:00

  • SA25 A Novel Patient-Reported Outcome Instrument for Meibomian Gland Dysfunction Disease Impact

    Jun 1, 2023, 00:00

  • EE137 Comparison of the Cost-Effectiveness of Sequential Treatment with Abaloparatide Followed By Alendronate between US Women and Men at Increased Risk of Fracture

    Jun 1, 2023, 00:00

  • EE258 National Trends in Costs and Site of Service of Infused Disease Modifying Therapies for Multiple Sclerosis

    Jun 1, 2023, 00:00

  • PCR37 Translation and Cultural Adaptation of the Glaucoma Quality of Life-15 Questionnaire to the Romanian Population

    Jun 1, 2023, 00:00

  • EE76 Budget Impact of Faricimab in Patients with Diabetic Macular Edema and Neovascular Age Related Degeneration in Canada

    Jun 1, 2023, 00:00

  • CO180 Persistent Opioid Use after Hospital Admissions for Surgery in New Zealand

    Jun 1, 2023, 00:00

  • EE495 Cost-Effectiveness of Pembrolizumab + Axitinib Versus Nivolumab + Ipilimumab As First-Line Treatment of Advanced Renal Cell Carcinoma in the Private Healthcare System in Brazil

    Jun 1, 2023, 00:00

  • CO179 Potential Health and Economic Outcomes of a Blood-Based Genomic Test As a Prescreen for Lung Cancer in the US Medicare Population

    Jun 1, 2023, 00:00

  • P43 Critical Appraisal of Drug Pricing for Advanced Breast Cancer Medications Approvals in Brazil (2007 - 2022) and Comparison with Major National Economic Indicators

    Jun 1, 2023, 00:00

  • PCR131 Expanded Diagnoses Outside of Specialized Amyloidosis Centers: Results from the Amyloidosis Research Consortium's 2022 Community Survey

    Jun 1, 2023, 00:00

  • EPH97 Application of Self-Protective Behaviors in Balancing Objective and Subjective COVID-19 Risk Assessments Among Residents in an Urban Setting

    Jun 1, 2023, 00:00

  • EE296 The Total Cost of Preeclampsia in the Ecuadorian Health System

    Jun 1, 2023, 00:00

  • MSR29 Application of Bayesian Multi-Parameter Evidence Synthesis to Achieve Clinical Plausibility of Lifetime Survival Extrapolations in First-Line Advanced Non-Small Cell Lung Cancer (aNSCLC)

    Jun 1, 2023, 00:00

  • MSR14 Association of Social Determinants of Health and HIV Pre-Exposure Prophylaxis (PREP) to Need Ratio on the County Level in the United States

    Jun 1, 2023, 00:00

  • EE180 Indirect Costs Associated with Preterm Birth in the United States

    Jun 1, 2023, 00:00

  • PCR57 The Role of Patient Activation and Social Support in Health Management Among US Adults with Type 2 Diabetes

    Jun 1, 2023, 00:00

  • PCR12 Delayed Care Among Low-Income Adults during the COVID-19 Pandemic: A US Population-Based Study

    Jun 1, 2023, 00:00

  • MSR94 Unraveling the Threads of Overlapping Coverage Among the Three Most Commonly Explored Biomedical Databases

    Jun 1, 2023, 00:00

  • EE128 Cost-Effectiveness of Switching from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide Vs. Entecavir for Chronic Hepatitis B Patients in Greece

    Jun 1, 2023, 00:00

  • HTA67 Evidence Gaps in Evaluating Comparative Effectiveness, Safety, and Cost-Effectiveness of Biologics in Health Technology Assessment (HTA) Submissions for the Treatment of Severe Asthma

    Jun 1, 2023, 00:00

  • PCR11 Minority Stressors, HIV/AIDS Acquisition Stress, Prep Stigma, and Willingness to Use Prep Among Men Who Have Sex with Men: A Latent Profile Analysis

    Jun 1, 2023, 00:00

  • RWD97 Implementing a Quality Assurance Program for Technology-Enabled Curation of Oncology Real-World Data

    Jun 1, 2023, 00:00

  • EE89 The Impact of Different Discounting Rates on Cost-Effectiveness Outcomes in Chronic Disease Populations: Hemophilia A As an Exemplary Disease

    Jun 1, 2023, 00:00

  • EE457 Major Ischemic or Hemorrhagic Events and Associated Costs Among Anticoagulated Patients with Non-Valvular Atrial Fibrillation in US Health Plans

    Jun 1, 2023, 00:00

  • EE429 Cost-Effectiveness of Sotagliflozin for the Treatment of Recent Worsening Heart Failure with Diabetes

    Jun 1, 2023, 00:00

  • HTA33 Using the Single Profile Preference Method to Estimate Value Sets for Expanded Descriptive Systems

    Jun 1, 2023, 00:00

  • HPR59 Influence of Institute for Clinical and Economic Review (ICER) Reports in Formulary Decision Making

    Jun 1, 2023, 00:00

  • HPR145 Authorizations of Therapeutic Biologics in Saudi Arabia and the US (1982-2021)

    Jun 1, 2023, 00:00

  • HSD84 Prescription Antitussive Use Trajectories and Their Characteristics Among Patients with Chronic Cough in Florida

    Jun 1, 2023, 00:00

  • CO103 Real-World Effectiveness of Sotrovimab for the Early Treatment of COVID-19: Evidence from the National COVID Cohort Collaborative (N3C)

    Jun 1, 2023, 00:00

  • OP2 Race and Social Determinants of Health Data Inform Blue Cross and Blue Shield of Louisiana’s Understanding of Its Medicare Advantage Members

    Jun 1, 2023, 00:00

  • EE424 Economic Burden of Chronic Kidney Disease in India: A Targeted Literature Review

    Jun 1, 2023, 00:00

  • OP4 Prioritization of ADT Notifications Improves Efficiency of New Blue Cross and Blue Shield of Louisiana Care Management Referral Process

    Jun 1, 2023, 00:00

  • HPR127 Evaluation of the Spatial Accessibility to Inpatient Services in Beijing, China

    Jun 1, 2023, 00:00

  • HTA99 Advancing Towards International HTA Collaboration: A Review of International Network Activities to Support HTA Efforts in Ex-Europe Low-Middle-Income Countries (LMICS)

    Jun 1, 2023, 00:00

  • EE568 Challenges to Hepatitis C Treatment Access in Vietnam: A Micro-Costing Study

    Jun 1, 2023, 00:00

  • MSR107 Assessment of the Power of ITCs to Detect Minimally Important Treatment Effects in Subsequent Head-to-Head Trials

    Jun 1, 2023, 00:00

  • EE14 Cost-Effectiveness of Non-Pharmaceutical Interventions (NPI), Vaccines and the Combination of NPI and Vaccines in Managing the COVID Pandemic

    Jun 1, 2023, 00:00

  • EE499 Real-World Outpatient Cost of Care Among Patients with Non-Small Cell Lung Cancer (NSCLC) Treated in the US Community

    Jun 1, 2023, 00:00

  • CO36 Keratometry, Intraocular Pressure, and Visual Acuity at the Onset of Ophthalmic Conditions in the Real-World Setting

    Jun 1, 2023, 00:00

  • HPR115 Patient and Provider Factors Associated with Filgrastim Biosimilar Uptake in the U.S.

    Jun 1, 2023, 00:00

  • RWD24 Veno-Occlusive Disease (VOD) Incidence and Treatment Trends Insights from Latest Systematic Review of Case Reports (2018-2023)

    Jun 1, 2023, 00:00

  • HTA24 The Use of Real-World Data in Decision Making for Oncology: A Review of Recent Health Technology Appraisals in the United Kingdom

    Jun 1, 2023, 00:00

  • EE449 Use of Novel and Social Elements of Value in Cost-Effectiveness Analyses

    Jun 1, 2023, 00:00

  • MSR100 Validation of a Mixed Model for Repeated Measures Approach to Including Trials with Varying Follow-up in Indirect Treatment Comparisons of Long-Term Outcomes

    Jun 1, 2023, 00:00

  • EPH102 Modeling the Population Health Impact of Nicotine Misperceptions

    Jun 1, 2023, 00:00

  • HSD70 Strategies Used and Degree of Implementation of Clinical Practice Guidelines during the Year 2022 in Colombia: Descriptive Observational Study

    Jun 1, 2023, 00:00

  • RWD157 Healthcare Resource Utilization and Cost of Care in Patients with BRAF-Mutated Unresectable/Metastatic Melanoma in the US

    Jun 1, 2023, 00:00

  • HSD68 Improving Care Via Timely Health Information Exchange: A Blue Cross and Blue Shield of Louisiana ADT System Referral Program Evaluation

    Jun 1, 2023, 00:00

  • EE285 Evaluating the Face Validity of Health State Utility Values (HSUVS) for Metachromatic Leukodystrophy (MLD)

    Jun 1, 2023, 00:00

  • EPH51 Algorithms for Identifying Immunocompromised Adults in Administrative Claims Data – a Targeted Literature Review

    Jun 1, 2023, 00:00

  • EE301 Patient Characteristics, Healthcare Resource Utilization, and Costs for Persistent Chronic Cough Vs. Chronic Cough without Persistent Cough in the United States

    Jun 1, 2023, 00:00

  • HPR31 Value-Based Purchasing Arrangements in Medicaid Programs: Targeted Review

    Jun 1, 2023, 00:00

  • PCR80 Analysis of the Use of Instruments for Collecting Patient-Reported Outcomes (PROS) in Pediatric Asthma Research

    Jun 1, 2023, 00:00

  • HTA25 Factors Including Real-World Evidence (RWE) That Play a Role in the HTA Recommendation of Oncology Drug Submissions Based on Phase II and/or Single Arm Trial Data

    Jun 1, 2023, 00:00

  • EPH10 Carbapenem-Resistant Gram-Negative Pathogens in Brazil: Analysis from Patients in a Laboratory Network

    Jun 1, 2023, 00:00

  • PCR147 Investigating the Patterns of Health-Related Quality of Life and Factors Associated with It Using Latent Class Analysis Among West Virginians

    Jun 1, 2023, 00:00

  • CO157 Recurrence-Free Survival (RFS) As a Surrogate Endpoint for Overall Survival (OS) in Adults with Early-Stage Hepatocellular Carcinoma (HCC): A Correlation Meta-Analysis of Randomized Controlled Trials (RCTS)

    Jun 1, 2023, 00:00

  • HSD103 Impact of COVID-19 on Delivery of Cancer Care: Real-World Insights from Community Oncology Research Evaluations (CORE)

    Jun 1, 2023, 00:00

  • CO80 Improvements in Activity and Work Productivity in Patients Treated with Mepolizumab across Eosinophilic Diseases

    Jun 1, 2023, 00:00

  • RWD124 Understanding the Value of Chart Abstraction for Assessing Oral Treatment History in the Oncology Outpatient Setting

    Jun 1, 2023, 00:00

  • SA27 Utility Maximization Vs Regret Minimization: Choice Behavior Under Uncertainty

    Jun 1, 2023, 00:00

  • HSD4 Opioid Use Among Migraine Patients Treated with Acute and Preventive Treatment

    Jun 1, 2023, 00:00

  • EE360 Measuring Catastrophic Costs Due to Tuberculosis in Colombia, 2021

    Jun 1, 2023, 00:00

  • EPH62 Annual Burden of Non-COVID-19 Respiratory Tract Infections in the Pre- to Post- Pandemic Eras: Analysis from the Anlitiks’ All Payor Claims Database

    Jun 1, 2023, 00:00

  • CO142 Evaluating the Impact of the COVID-19 Pandemic on Acute Ischemic Stroke Outcomes in the Stroke Belt

    Jun 1, 2023, 00:00

  • HPR54 A Review and Evaluation of the UK’s Innovative Licensing and Access Pathway

    Jun 1, 2023, 00:00

  • EPH87 COPD Exacerbation Profile in Chile: Preliminary Results from Integramédica Cohort 2018–2020

    Jun 1, 2023, 00:00

  • CO217 Treatment Options for Management of Facial Angiofibroma Associated with Tuberous Sclerosis Complex: A Systematic Review of Evidence of Clinical Effectiveness and Cost-Effectiveness

    Jun 1, 2023, 00:00

  • PCR77 “It Shocks Me That There Is Not Something like This Already in Place”: Patient Perspectives for Enhancing Pan-Canadian Data Sharing for Precision Oncology

    Jun 1, 2023, 00:00

  • EE61 Cost Effectiveness of Treating Ivig-Resistant Kawasaki Disease Children with Second Round IVIG Versus Infliximab

    Jun 1, 2023, 00:00

  • CO27 Real-World Treatment Response and Persistence Among Black and Non-Black Patients with Metastatic Castration-Sensitive Prostate Cancer Treated with Apalutamide in a Urology Setting

    Jun 1, 2023, 00:00

  • EE37 Economic Burden Associated with Immune-Related Adverse Events Induced By Immune Checkpoint Inhibitors Among Older Adults with Non-Small Cell Lung Cancer

    Jun 1, 2023, 00:00

  • EPH2 Using Drug Package Insert Data to Identify Statin-Related Prescribing Cascades - an Evaluation of Findings from Side Effect Resource (SIDER) and Commercial Claims Data

    Jun 1, 2023, 00:00

  • CO176 Spinal Muscular Atrophy (SMA) Disease-Related Complications Decreased Over Time after Start of Nusinersen Treatment

    Jun 1, 2023, 00:00

  • RWD36 Healthcare Resource Utilization in Patients with Hidradenitis Suppurativa in Five European Countries and the USA Using Real World Evidence

    Jun 1, 2023, 00:00

  • CO74 Impact of Current Management on QOL and Mental Health in Pre and Postmenopausal Breast Cancer Patients; An Epidemiological Observational Study in a Tertiary Care Hospital in South India

    Jun 1, 2023, 00:00

  • MT42 HTA Landscape of Medical Devices in Canada

    Jun 1, 2023, 00:00

  • HPR12 Patient Reported Outcomes in Psoriasis Over Time: Differences By Sex from Three Cross-Sectional, Real World Studies in the United States

    Jun 1, 2023, 00:00

  • RWD7 Reproduction of the Control Group in REMDACTA Trial Using the Millennial Medical Record, an Electric Health Record Database, in Japan

    Jun 1, 2023, 00:00

  • EPH139 A Secondary Analysis of the Cross-Cultural Validation of Multi-Dimensional Postpartum Health PROMs, and Suggestions for Improving Their Validity and Administration

    Jun 1, 2023, 00:00

  • EE44 Estimating a Cost-Effectiveness Threshold for Health Care Decision-Making in China: Oncology Prevention Versus Treatment

    Jun 1, 2023, 00:00

  • HSD77 Use and Prescribing Patterns of Disease Modifying Agents in Patients with Multiple Sclerosis Based on Payer Type and Prescribers’ Specialty

    Jun 1, 2023, 00:00

  • EE141 Treatment Patterns and Health Care Spending Among Medicare Beneficiaries with Huntington's Disease

    Jun 1, 2023, 00:00

  • HPR81 Effect of Medicare Eligibility at Age 65 Years on Prescription of High-Risk Medications in Individuals with Multiple Chronic Conditions

    Jun 1, 2023, 00:00

  • MSR58 Relating Heterotopic Ossification Volume to Joint Function And Quality of Life: A Simulation Study in Fibrodysplasia Ossificans Progressiva (FOP)

    Jun 1, 2023, 00:00

  • PCR160 Suitability of Patient-Reported Outcomes Measure Information System (PROMIS) Parent Proxy (PP) Mobility Questionnaire in Typically Developing Children Aged 3-4 Years

    Jun 1, 2023, 00:00

  • MSR95 Impact of Adherence on Real-World Performance of Multi Cancer Early Detection (MCED) Tests: A Model-Based Analysis

    Jun 1, 2023, 00:00

  • PCR128 Measurement of Health-Related Quality of Life in Pediatric Genetic Conditions: A Scoping Review

    Jun 1, 2023, 00:00

  • CO117 Real-World Treatment Patterns and Outcomes in Unresectable Advanced and Metastatic Biliary Tract Cancers (BTC): A Literature Review

    Jun 1, 2023, 00:00

  • MSR17 Imputation of Line-Level Medical Costs Using a Gradient Descent Boosting Regressor Model

    Jun 1, 2023, 00:00

  • CO71 The Impact of Socioeconomic Status (SES), Insurance Type, and Treatment Facility on Survival in Metastatic Prostate Cancer (MPC): A Systematic Literature Review (SLR) of Social Determinants of Health (SDOH)

    Jun 1, 2023, 00:00

  • CO26 Impact in Health Outcomes of Anti-PD(L)1 Inhibitors to Treat Early-Stage Cancers in Belgium

    Jun 1, 2023, 00:00

  • CO189 Metabolic and Bariatric Surgery Utilization Trends in the United States: Evidence from 2012–2021 National Electronic Medical Records Data

    Jun 1, 2023, 00:00

  • EE188 Budget Impact Analysis of Faricimab for Treating Patients with Diabetes Macular Edema or Neovascular Age-Related Macular Degeneration in Panama

    Jun 1, 2023, 00:00

  • CO86 Improving External Validity of Trial Outcomes When Estimating Subgroup QALY Gains: A Case Study of Pembrolizumab±Chemotherapy Vs. Cetuximab+Platinum-Based Chemotherapy (‘EXTREME’) in Squamous Cell Carcinoma of the Head and Neck

    Jun 1, 2023, 00:00

  • CO63 Comparative Clinical Effectiveness of Monoclonal Antibodies for the Treatment of Relapsing Multiple Sclerosis: A Systematic Review and Network Meta-Analysis

    Jun 1, 2023, 00:00

  • HSD110 Trends in the Therapeutic Management of Localized Scleroderma in the Real-World Setting

    Jun 1, 2023, 00:00
  • «
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27 (current)
  • 28
  • 29
  • 30
  • »